{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,17]],"date-time":"2026-05-17T05:54:56Z","timestamp":1778997296746,"version":"3.51.4"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2019,8,29]],"date-time":"2019-08-29T00:00:00Z","timestamp":1567036800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,8,29]],"date-time":"2019-08-29T00:00:00Z","timestamp":1567036800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001807","name":"FAPESP","doi-asserted-by":"crossref","award":["2007\/03845-0"],"award-info":[{"award-number":["2007\/03845-0"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1007\/s00520-019-05044-0","type":"journal-article","created":{"date-parts":[[2019,8,29]],"date-time":"2019-08-29T08:58:23Z","timestamp":1567069103000},"page":"2265-2271","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Prevalence and risk factors of medication-related osteonecrosis of the jaw in osteoporotic and breast cancer patients: a cross-sectional study"],"prefix":"10.1007","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3927-0289","authenticated-orcid":false,"given":"Ana Laura","family":"Soares","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S\u00e9rgio","family":"Simon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luiz Henrique","family":"Gebrim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Afonso Celso P.","family":"Naz\u00e1rio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9186-2834","authenticated-orcid":false,"given":"Marise","family":"Lazaretti-Castro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,8,29]]},"reference":[{"key":"5044_CR1","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1210\/edrv.19.1.0325","volume":"19","author":"H Fleisch","year":"1998","unstructured":"Fleisch H (1998) Bisphosphonates: mechanisms of action. Endocr Rev 19:80\u2013100. \nhttps:\/\/doi.org\/10.1210\/edrv.19.1.0325","journal-title":"Endocr Rev"},{"key":"5044_CR2","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1016\/j.joms.2014.04.031","volume":"72","author":"SL Ruggiero","year":"2014","unstructured":"Ruggiero SL, Dodson TB, Fantasia J, Goodday R, Aghaloo T, Mehrotra B, O\u2019Ryan F (2014) American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw--2014 update. J Oral Maxillofac Surg 72:1938\u20131956. \nhttps:\/\/doi.org\/10.1016\/j.joms.2014.04.031","journal-title":"J Oral Maxillofac Surg"},{"key":"5044_CR3","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/s1470-2045(06)70726-4","volume":"7","author":"CA Migliorati","year":"2006","unstructured":"Migliorati CA, Siegel MA, Elting LS (2006) Bisphosphonate-associated osteonecrosis: a long-term complication of bisphosphonate treatment. Lancet Oncol 7:508\u2013514. \nhttps:\/\/doi.org\/10.1016\/s1470-2045(06)70726-4","journal-title":"Lancet Oncol"},{"key":"5044_CR4","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1016\/S0278-2391(03)00720-1","volume":"61","author":"RE Marx","year":"2003","unstructured":"Marx RE (2003) Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic. J Oral Maxillofac Surg 61:1115\u20131117. \nhttps:\/\/doi.org\/10.1016\/S0278-2391(03)00720-1","journal-title":"J Oral Maxillofac Surg"},{"key":"5044_CR5","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/jbmr.2405","volume":"30","author":"AA Khan","year":"2015","unstructured":"Khan AA, Morrison A, Hanley DA, Felsenberg D, McCauley LK, O'Ryan F, Reid IR, Ruggiero SL, Taguchi A, Tetradis S, Watts NB, Brandi ML, Peters E, Guise T, Eastell R, Cheung AM, Morin SN, Masri B, Cooper C, Morgan SL, Obermayer-Pietsch B, Langdahl BL, al Dabagh R, Davison KS, Kendler DL, S\u00e1ndor GK, Josse RG, Bhandari M, el Rabbany M, Pierroz DD, Sulimani R, Saunders DP, Brown JP, Compston J, on behalf of the International Task Force on Osteonecrosis of the Jaw (2015) Diagnosis and management of osteonecrosis of the jaw: a systematic review and international consensus. J Bone Miner Res 30:3\u201323. \nhttps:\/\/doi.org\/10.1002\/jbmr.2405","journal-title":"J Bone Miner Res"},{"key":"5044_CR6","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1007\/s00198-013-2575-3","volume":"25","author":"SH Lee","year":"2014","unstructured":"Lee SH, Chang SS, Lee M, Chan RC, Lee CC (2014) Risk of osteonecrosis in patients taking bisphosphonates for prevention of osteoporosis: a systematic review and meta-analysis. Osteoporos Int 25:1131\u20131139. \nhttps:\/\/doi.org\/10.1007\/s00198-013-2575-3","journal-title":"Osteoporos Int"},{"key":"5044_CR7","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1007\/s11914-010-0008-1","volume":"8","author":"SK Kumar","year":"2010","unstructured":"Kumar SK, Gorur A, Schaudinn C, Shuler CF, Costerton JW, Sedghizadeh PP (2010) The role of microbial biofilms in osteonecrosis of the jaw associated with bisphosphonate therapy. Curr Osteoporos Rep 8:40\u201348. \nhttps:\/\/doi.org\/10.1007\/s11914-010-0008-1","journal-title":"Curr Osteoporos Rep"},{"key":"5044_CR8","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.oooo.2017.07.011","volume":"124","author":"JM Bugueno","year":"2017","unstructured":"Bugueno JM, Migliorati CA (2017) AAOM clinical practice statement: subject: the use of serum C-terminal telopeptide cross-link of type 1 collagen (CTX) testing in predicting risk of osteonecrosis of the jaw (ONJ). Oral Surg Oral Med Oral Pathol Oral Radiol 124:367\u2013368. \nhttps:\/\/doi.org\/10.1016\/j.oooo.2017.07.011","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"5044_CR9","doi-asserted-by":"publisher","first-page":"e137","DOI":"10.1097\/scs.0000000000004224","volume":"29","author":"A Peisker","year":"2018","unstructured":"Peisker A, Raschke GF, Fahmy MD, Guentsch A, Roshanghias K, Konig KC, Schultze-Mosgau S (2018) Cross-sectional study of four serological bone turnover markers for the risk assessment of medication-related osteonecrosis of the jaw. J Craniofac Surg 29:e137\u2013e140. \nhttps:\/\/doi.org\/10.1097\/scs.0000000000004224","journal-title":"J Craniofac Surg"},{"key":"5044_CR10","doi-asserted-by":"publisher","first-page":"e26","DOI":"10.4317\/medoral.22763","volume":"24","author":"AI Lorenzo-Pouso","year":"2019","unstructured":"Lorenzo-Pouso AI, P\u00e9rez-Say\u00e1ns M, Gonz\u00e1lez-Palanca S, Chamorro-Petronacci C, Bag\u00e1n J, Garc\u00eda-Garc\u00eda A (2019) Biomarkers to predict the onset of biphosphonate-related osteonecrosis of the jaw: a systematic review. Med Oral Patol Oral Cir Bucal 24:e26\u2013e36. \nhttps:\/\/doi.org\/10.4317\/medoral.22763","journal-title":"Med Oral Patol Oral Cir Bucal"},{"key":"5044_CR11","doi-asserted-by":"publisher","first-page":"3955","DOI":"10.1158\/1078-0432.ccr-14-0434","volume":"20","author":"CG Patel","year":"2014","unstructured":"Patel CG, Yee AJ, Scullen TA, Nemani N, Santo L, Richardson PG, Laubach JP, Ghobrial IM, Schlossman RL, Munshi NC, Anderson KC, Raje NS (2014) Biomarkers of bone remodeling in multiple myeloma patients to tailor bisphosphonate therapy. Clin Cancer Res 20:3955\u20133961. \nhttps:\/\/doi.org\/10.1158\/1078-0432.ccr-14-0434","journal-title":"Clin Cancer Res"},{"key":"5044_CR12","first-page":"1961","volume":"27","author":"G Oremek","year":"2007","unstructured":"Oremek G, Sauer-Eppel H, Klepzig M (2007) Total procollagen type 1 amino-terminal propeptide (total P1NP) as a bone metastasis marker in gynecological carcinomas. Anticancer Res 27:1961\u20131962","journal-title":"Anticancer Res"},{"key":"5044_CR13","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/j.oooo.2019.02.014","volume":"127","author":"V Moraschini","year":"2019","unstructured":"Moraschini V, de Almeida DCF, Figueredo CM, Calasans-Maia MD (2019) Association between biomarkers and medication-related osteonecrosis of the jaws: a systematic review. Oral Surg Oral Med Oral Pathol Oral Radiol 127:504\u2013515. \nhttps:\/\/doi.org\/10.1016\/j.oooo.2019.02.014","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"5044_CR14","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.joms.2006.11.003","volume":"65","author":"Advisory Task Force on Bisphosphonate-Related Ostenonecrosis of the Jaws, American Association of Oral and Maxillofacial Surgeons","year":"2007","unstructured":"Advisory Task Force on Bisphosphonate-Related Ostenonecrosis of the Jaws, American Association of Oral and Maxillofacial Surgeons (2007) American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws. J Oral Maxillofac Surg 65:369\u2013376. \nhttps:\/\/doi.org\/10.1016\/j.joms.2006.11.003","journal-title":"J Oral Maxillofac Surg"},{"issue":"4","key":"5044_CR15","doi-asserted-by":"publisher","first-page":"ix","DOI":"10.1016\/j.coms.2015.08.005","volume":"27","author":"Salvatore L. Ruggiero","year":"2015","unstructured":"Ruggiero SL (2015) Medication-related osteonecrosis of the jaw(MRONJ) that is linked to the treatment of malignant. Introduction. Oral Maxillofac Surg Clin North Am 27:ix. \nhttps:\/\/doi.org\/10.1016\/j.coms.2015.08.005","journal-title":"Oral and Maxillofacial Surgery Clinics of North America"},{"key":"5044_CR16","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.coms.2015.06.008","volume":"27","author":"SL Ruggiero","year":"2015","unstructured":"Ruggiero SL (2015) Diagnosis and staging of medication-related osteonecrosis of the jaw. Oral Maxillofac Surg Clin North Am 27:479\u2013487. \nhttps:\/\/doi.org\/10.1016\/j.coms.2015.06.008","journal-title":"Oral Maxillofac Surg Clin North Am"},{"key":"5044_CR17","unstructured":"Meneghini LS, Nogueira GT, Tavares LB, Albergaria B, Veloso TRG, de Alencar CO, Bianchi PR (2017) Evaluation of risk factors for osteonecrosis in patients using biophosphonates in HUCAM \/ UFES. Braz J Periodontol"},{"key":"5044_CR18","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1093\/annonc\/mdr435","volume":"23","author":"F Saad","year":"2012","unstructured":"Saad F, Brown JE, Van Poznak C et al (2012) Incidence, risk factors, and outcomes of osteonecrosis of the jaw: integrated analysis from three blinded active-controlled phase III trials in cancer patients with bone metastases. Ann Oncol 23:1341\u20131347. \nhttps:\/\/doi.org\/10.1093\/annonc\/mdr435","journal-title":"Ann Oncol"},{"key":"5044_CR19","doi-asserted-by":"publisher","first-page":"365","DOI":"10.5125\/jkaoms.2016.42.6.365","volume":"42","author":"MV Cuevas-Gonzalez","year":"2016","unstructured":"Cuevas-Gonzalez MV, Diaz-Aguirre CM, Echevarria YPE, Cuevas-Gonzalez JC (2016) Prevalence of osteonecrosis of the jaw and oral characteristics of oncologic patients treated with bisphosphonates at the General Hospital of Mexico. J Korean Assoc Oral Maxillofac Surg 42:365\u2013369. \nhttps:\/\/doi.org\/10.5125\/jkaoms.2016.42.6.365","journal-title":"J Korean Assoc Oral Maxillofac Surg"},{"key":"5044_CR20","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1007\/s10266-015-0207-4","volume":"104","author":"A Matsuo","year":"2016","unstructured":"Matsuo A, Hamada H, Takahashi H, Okamoto A, Kaise H, Chikazu D (2016) Evaluation of dental implants as a risk factor for the development of bisphosphonate-related osteonecrosis of the jaw in breast cancer patients. Odontology 104:363\u2013371. \nhttps:\/\/doi.org\/10.1007\/s10266-015-0207-4","journal-title":"Odontology"},{"key":"5044_CR21","doi-asserted-by":"publisher","first-page":"3421","DOI":"10.1007\/s00520-015-2689-6","volume":"23","author":"PB de Lima","year":"2015","unstructured":"de Lima PB, Brasil VL, de Castro JF, de Moraes Ramos-Perez FM, Alves FA, Pontual MLDA, Perez DEDC (2015) Knowledge and attitudes of Brazilian dental students and dentists regarding bisphosphonate-related osteonecrosis of the jaw. Support Care Cancer 23:3421\u20133426. \nhttps:\/\/doi.org\/10.1007\/s00520-015-2689-6","journal-title":"Support Care Cancer"},{"key":"5044_CR22","first-page":"69","volume":"11","author":"F Rodrigues","year":"2014","unstructured":"Rodrigues F, Carrion SJ, M\u00e1rmora A, C\u00e2mara B, Silva MB (2014) A questionnaire survey on the knowledge regarding bisphosphonates and implant dentistry: indications, uses, and jaw-associated osteonecrosis at Porto Alegre \u2013 Brazil. ImplantNews 11:69\u201376","journal-title":"ImplantNews"},{"key":"5044_CR23","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1359\/jbmr.090203","volume":"24","author":"S Baim","year":"2009","unstructured":"Baim S, Miller PD (2009) Assessing the clinical utility of serum CTX in postmenopausal osteoporosis and its use in predicting risk of osteonecrosis of the jaw. J Bone Miner Res 24:561\u2013574. \nhttps:\/\/doi.org\/10.1359\/jbmr.090203","journal-title":"J Bone Miner Res"},{"key":"5044_CR24","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.ijom.2016.10.009","volume":"46","author":"KJ dal Pra","year":"2017","unstructured":"dal Pra KJ, Lemos CA, Okamoto R, Soubhia AM, Pellizzer EP (2017) Efficacy of the C-terminal telopeptide test in predicting the development of bisphosphonate-related osteonecrosis of the jaw: a systematic review. Int J Oral Maxillofac Surg 46:151\u2013156. \nhttps:\/\/doi.org\/10.1016\/j.ijom.2016.10.009","journal-title":"Int J Oral Maxillofac Surg"},{"key":"5044_CR25","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.tripleo.2008.01.033","volume":"106","author":"S Lehrer","year":"2008","unstructured":"Lehrer S, Montazem A, Ramanathan L, Pessin-Minsley M, Pfail J, Stock RG, Kogan R (2008) Normal serum bone markers in bisphosphonate-induced osteonecrosis of the jaws. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 106:389\u2013391. \nhttps:\/\/doi.org\/10.1016\/j.tripleo.2008.01.033","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"5044_CR26","doi-asserted-by":"publisher","first-page":"2397","DOI":"10.1016\/j.joms.2007.08.003","volume":"65","author":"RE Marx","year":"2007","unstructured":"Marx RE, Cillo JE Jr, Ulloa JJ (2007) Oral bisphosphonate-induced osteonecrosis: risk factors, prediction of risk using serum CTX testing, prevention, and treatment. J Oral Maxillofac Surg 65:2397\u20132410. \nhttps:\/\/doi.org\/10.1016\/j.joms.2007.08.003","journal-title":"J Oral Maxillofac Surg"},{"key":"5044_CR27","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1016\/j.joms.2015.09.028","volume":"74","author":"V Thumbigere-Math","year":"2016","unstructured":"Thumbigere-Math V, Michalowicz BS, Hughes PJ, Basi DL, Tsai ML, Swenson KK, Rockwell L, Gopalakrishnan R (2016) Serum markers of bone turnover and angiogenesis in patients with bisphosphonate-related osteonecrosis of the jaw after discontinuation of long-term intravenous bisphosphonate therapy. J Oral Maxillofac Surg 74:738\u2013746. \nhttps:\/\/doi.org\/10.1016\/j.joms.2015.09.028","journal-title":"J Oral Maxillofac Surg"},{"key":"5044_CR28","doi-asserted-by":"publisher","first-page":"2068","DOI":"10.1016\/j.jcms.2017.09.015","volume":"45","author":"N Heim","year":"2017","unstructured":"Heim N, Warwas FB, Wilms CT, Reich RH, Martini M (2017) Vitamin D (25-OHD) deficiency may increase the prevalence of medication-related osteonecrosis of the jaw. J Craniomaxillofac Surg 45:2068\u20132074. \nhttps:\/\/doi.org\/10.1016\/j.jcms.2017.09.015","journal-title":"J Craniomaxillofac Surg"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-019-05044-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00520-019-05044-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-019-05044-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,27]],"date-time":"2020-08-27T23:34:34Z","timestamp":1598571274000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00520-019-05044-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,29]]},"references-count":28,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["5044"],"URL":"https:\/\/doi.org\/10.1007\/s00520-019-05044-0","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,29]]},"assertion":[{"value":"9 November 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 August 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in this study were in accordance with the ethical standards of the institutional research committee (CEP approval No.0351\/07) and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Informed consent was obtained from all individual participants included in this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}